高级检索
当前位置: 首页 > 详情页

CpG-oligodeoxynucleotides may be effective for preventing ionizing radiation induced pulmonary fibrosis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Radiotherapy, Lanzhou General Hospital of PLA, Lanzhou, China [2]Department of Radiation Medicine, Faculty of Naval Medicine, Second Military Medical University, Shanghai, China [3]Department of Thoracic Surgery, Tongren Hospital, Shanghai Jiao Tong University of Medicine Shanghai, China
出处:
ISSN:

关键词: Radiation Pulmonary fibrosis CpG-ODN Macrophage TGF-beta 1 Smad 2/3

摘要:
Pulmonary fibrosis is a serious adverse effect of radiotherapy for thoracic tumor, which is believed to be a process that is tightly regulated by the phenotype of the developing Th response after radiation. Here, we will investigate whether CpG-oligodeoxynucleotides (ODN) prevent radiation-induced pulmonary fibrosis by shifting the imbalance of Th1 and Th2 response and summarizes the possible mechanism. In this study, female C57BL/6 mice were chosen to preform pulmonary fibrosis model, the whole-thorax of mice was exposed to a single radiation dose of 15 Gy. When irradiated mice were administrated with CpG-ODN, forming of pulmonary fibrosis was significantly prevented. Th2-related cytokines (IL-4 and IL-13) expression decreased, Th1 related-cytokine (IFN-gamma and IL-12) expression increased. Alveolar macrophage accumulation was reduced in irradiated tissue. Profibrotic cytokine TGF-beta 1 expression stayed at lower level. In TGF-beta 1-Smad-dependent pathways, TGF-beta 1, T beta R and phosphor-Smad 2/3 were down regulated, and Smad 7 was up regulated. These suggested that CpG-ODN prevented pulmonary fibrosis after radiation. The mechanism might be associated with reduction of alveolar macrophages accumulation and profibrogenic cytokines secretion TGF-beta 1 through stimulating the combination of Th1-promoting and Th2-limiting responses after radiation, and finally inhibited the fibrosis-related downstream TGF-beta 1-Smad-dependent pathway.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 毒理学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 毒理学
JCR分区:
出版当年[2016]版:
Q1 TOXICOLOGY
最新[2023]版:
Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Radiotherapy, Lanzhou General Hospital of PLA, Lanzhou, China [*2]Department of radiotherapy, Lanzhou General Hospital of PLA, Lanzhou, 730050, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Radiotherapy, Lanzhou General Hospital of PLA, Lanzhou, China [2]Department of Radiation Medicine, Faculty of Naval Medicine, Second Military Medical University, Shanghai, China [3]Department of Thoracic Surgery, Tongren Hospital, Shanghai Jiao Tong University of Medicine Shanghai, China [*1]Section of Radiation Medicine, Department of Naval Medicine, Second Military Medical University, Shanghai, 200433, China. [*2]Department of radiotherapy, Lanzhou General Hospital of PLA, Lanzhou, 730050, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21166 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)